According to BeiGene 's latest financial reports the company's total liabilities are $2.26 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $2.26 B | 13.63% |
2022-12-31 | $1.99 B | -16.94% |
2021-12-31 | $2.40 B | 38.78% |
2020-12-31 | $1.73 B | 173.14% |
2019-12-31 | $0.63 B | 27.8% |
2018-12-31 | $0.49 B | 36.93% |
2017-12-31 | $0.36 B | 584.7% |
2016-12-31 | $52.9 M | 24.65% |
2015-12-31 | $42.44 M | 52.39% |
2014-12-31 | $27.85 M | -44.87% |
2013-12-31 | $50.52 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.62 B | -72.55% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $12.52 M | -99.45% | ๐บ๐ธ USA |